News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Q Therapeutics, Inc. And Johns Hopkins University Researchers Collaborate on Study of Human Neural Glial Cells in Treatment of ALS



10/21/2008 9:12:50 AM

SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc., announced today that studies are underway with Nicholas Maragakis, MD, and his research team at Johns Hopkins University to build on recent results showing that glial progenitor cells (GRPs) have a therapeutic benefit in a model of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. Results of the initial Johns Hopkins studies appear this week in Nature Neuroscience.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES